drugset / Trial / NCT05769257

A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery

NCT05769257 ↗

Phase 2 Completed 12 enrolled Intuitive Surgical
NaSingle-groupOpen-labelPrevention

Summary

This study evaluates the safety and feasibility of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation

Timeline

Start
2023-06-14
Primary completion
2024-03-18
Completion
2024-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject IS-001 Diagnostic / imaging agent 20 mg Intravenous

Indications